The administration of ACE inhibitors in the later phases of hypertension in SHR-SP rats also decreased mortality [77], suggesting that ACE inhibitors reduce cardiovascular risk and atherosclerosis in animals in different stages of cardiovascular disease. This evidence concerns the gene ACE and atherosclerosis.